Home › Asset managers › Compare 2025-2026 › American Century vs Franklin Templeton
American Century 2025-2026 · Franklin Templeton 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 43,403 | 42,227 | 741 | 435 | 98.3% | 97.9% |
| Board proposals | 35,023 | 34,084 | 621 | 318 | 98.2% | 97.9% |
| E&S shareholder proposals | 167 | 142 | 11 | 14 | 92.8% | 90.5% |
| Other items | 8,213 | 8,001 | 109 | 103 | 98.7% | 98.1% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
741 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | American Century | Franklin Templeton |
|---|---|---|---|---|---|---|
| TBS Holdings, Inc. | June 26, 2026 | Initiate Share Repurchase Program Capital Structure |
Other | Against | AGAINST 3 funds |
FOR 2 funds |
| TELEPHONE AND DATA SYSTEMS, INC. | May 21, 2026 | Approval of an amendment to the Company's Restated Certificate of Incorporation to provide for exculpation of officers Director Elections |
Other | For | FOR 6 funds |
AGAINST 1 fund |
| TEXAS INSTRUMENTS INCORPORATED | April 16, 2026 | Stockholder proposal to permit stockholders to act by written consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 6 funds |
FOR 10 funds |
| TEXAS PACIFIC LAND CORPORATION | November 6, 2025 | To consider a non-binding stockholder proposal to reduce the ownership threshold for stockholders to call a special stockholder meeting from 25% to 10%. Shareholder Rights and Defenses |
Other | Against | FOR 7 funds |
AGAINST 3 funds |
| THE BOEING COMPANY | April 17, 2026 | Action by Written Consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 5 funds |
FOR 1 fund |
| THE CIGNA GROUP | April 22, 2026 | Shareholder Proposal - Shareholder Right to Act by Written Consent Shareholder Rights and Defenses |
Other | Against | AGAINST 14 funds |
FOR 2 funds |
| THE ESTEE LAUDER COMPANIES INC. | November 13, 2025 | Approval of Amendments to the Restated Certificate of Incorporation to Eliminate the Monetary Liability of Certain Officers as Permitted by Delaware Law and to Make Certain Miscellaneous Changes to Article IV thereof. Director Elections |
Other | For | FOR 17 funds |
AGAINST 4 funds |
| THE HARTFORD INSURANCE GROUP, INC. | May 20, 2026 | Shareholder proposal that the Company adopt written consent rights for shareholders Shareholder Rights and Defenses |
Other | Against | AGAINST 11 funds |
FOR 6 funds |
| THE SHERWIN-WILLIAMS COMPANY | April 22, 2026 | Shareholder Proposal Regarding Shareholder Ability to Call a Special Meeting Shareholder Rights and Defenses |
Other | Against | AGAINST 6 funds |
FOR 3 funds |
| THE WESTERN UNION COMPANY | May 14, 2026 | Stockholder proposal regarding stockholder right to act by written consent Shareholder Rights and Defenses |
Other | Against | AGAINST 5 funds |
FOR 3 funds |
| Tohoku Electric Power Co., Inc. | June 25, 2026 | Amend Articles to Abolish Advisory Posts Corporate Governance |
Other | Against | AGAINST 3 funds |
FOR 2 funds |
| Toyo Suisan Kaisha, Ltd. | June 25, 2026 | Approve Restricted Stock Plan Compensation |
Other | Against | AGAINST 2 funds |
FOR 2 funds |
| UNITED AIRLINES HOLDINGS, INC. | May 19, 2026 | Advisory vote on stockholder proposal entitled "Shareholder Right to Act by Written Consent". Shareholder Rights and Defenses |
Other | Against | AGAINST 8 funds |
FOR 3 funds |
| VERISK ANALYTICS, INC. | May 19, 2026 | Shareholder Proposal - Shareholder Right to Act by Written Consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 9 funds |
FOR 5 funds |
| WEST PHARMACEUTICAL SERVICES, INC. | May 4, 2026 | Shareholder proposal regarding an independent Board Chair policy. Corporate Governance |
Other | Against | AGAINST 12 funds |
FOR 2 funds |
| WOODWARD, INC. | January 28, 2026 | Approve an amendment to the Certificate of Incorporation to eliminate cumulative voting rights in the election of directors. Shareholder Rights and Defenses |
Other | For | AGAINST 5 funds |
FOR 1 fund |
| WOOLWORTHS GROUP LTD | October 30, 2025 | Approve Farmed Seafood Reporting Environment or Climate |
Other | Against | AGAINST 4 funds |
FOR 2 funds |
| Yakult Honsha Co., Ltd. | June 24, 2026 | Approve Restricted Stock Plan Compensation |
Other | Against | AGAINST 2 funds |
FOR 2 funds |
| ZOETIS INC. | May 20, 2026 | Shareholder proposal to permit shareholder action by written consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 17 funds |
FOR 3 funds |
| ZSCALER, INC. | January 12, 2026 | To vote on a non-binding stockholder proposal requesting the declassification of our board of directors. Shareholder Rights and Defenses |
Other | Against | AGAINST 12 funds |
FOR 4 funds |
| 10X GENOMICS, INC. | June 4, 2026 | A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers; Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 1 fund |
| AAK AB | May 8, 2026 | Approve Incentive Program 2026/2029 for Key Employees Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| AB SAGAX | May 8, 2026 | APPROVE REMUNERATION REPORT Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. Compensation |
Board | For | AGAINST 6 funds |
FOR 2 funds |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 2 funds |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Approval of 2026 Equity Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| ACCENTURE PLC | January 28, 2026 | To approve the Amended and Restated Accenture plc 2010 Share Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 5 funds |
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval of an amendment to the 2022 ACCO Brands Corporation Incentive Plan to increase the number of shares available for future grant and eliminate fungible share counting provisions with respect to new awards. Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval, by non-binding advisory vote, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 1 fund |
| ACME UNITED CORPORATION | April 27, 2026 | Approval, by non-binding advisory vote, of the compensation of the named executive officers of the Company as described in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement; Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| ADIDAS AG | May 7, 2026 | REELECT NASSEF SAWIRIS TO THE SUPERVISORY BOARD Director Elections |
Board | For | FOR 4 funds |
AGAINST 6 funds |
| ADTALEM GLOBAL EDUCATION INC. | November 12, 2025 | Say-on-pay: Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| ADVANCED ENERGY INDUSTRIES, INC. | May 7, 2026 | Approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan; Compensation |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| AEROVIRONMENT, INC. | September 25, 2025 | Management proposal to approve the amendment and restatement of the company's 2021 equity incentive plan Compensation |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| AES CORP | April 29, 2026 | Approval, on an advisory basis, of the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 2 funds |
| AFFIRM HOLDINGS, INC. | December 15, 2025 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 4 funds |
| AGC, Inc. (Japan) | March 27, 2026 | Elect Director Hirai, Yoshinori Director Elections |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| AGILYSYS, INC. | September 4, 2025 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers set forth in the attached Proxy Statement Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as Amended, to increase the number of shares of common stock available thereunder by 2,000,000 shares. Compensation |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To vote, on an advisory basis, to approve the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| AIR LEASE CORPORATION | December 18, 2025 | Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to the named executive officers of Air Lease Corporation in connection with the merger (the ''Compensation Proposal''). Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| ALEXANDER & BALDWIN, INC. | March 9, 2026 | To consider and vote on a proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers that is based on or otherwise relates to the merger. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| ALIMENTATION COUCHE-TARD INC | September 3, 2025 | ELECTION OF DIRECTOR: MELANIE KAU Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| ALLY FINANCIAL INC. | May 6, 2026 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| ALPHABET INC. | June 5, 2026 | Advisory vote to approve compensation awarded to named executive officers Say-on-Pay |
Board | For | FOR 26 funds |
AGAINST 19 funds |
| AMC GLOBAL MEDIA INC. | June 16, 2026 | Vote on Proposal to Approve the Company's Amended and Restated 2011 Stock Plan for Non-Employee Directors Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| AMERICAN STATES WATER COMPANY | May 19, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 2 funds |
| AMERICAN STATES WATER COMPANY | May 19, 2026 | To approve the 2026 Stock Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| AMERICAN TOWER CORPORATION | May 20, 2026 | To approve the American Tower Corporation 2026 Equity Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 2 funds |
| AMERICAN WOODMARK CORPORATION | August 21, 2025 | Election of Directors: Emily C. Videtto Director Elections |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| AMERICAN WOODMARK CORPORATION | August 21, 2025 | To approve on an advisory basis the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| AMERICAS GOLD AND SILVER CORPORATION | June 23, 2026 | ELECT DIRECTOR PETER GOUDIE Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| AMICUS THERAPEUTICS, INC. | March 3, 2026 | To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| AMRIZE AG | April 21, 2026 | Re-election of Jan Jenisch as Chairman of the Board Corporate Governance |
Board | For | FOR 13 funds |
AGAINST 2 funds |
| AON PLC | June 26, 2026 | Advisory resolution to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| APA CORPORATION | May 21, 2026 | Advisory vote to approve the compensation of APA's named executive officers Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 4 funds |
| APOGEE ENTERPRISES, INC. | June 24, 2026 | APPROVAL OF THE APOGEE ENTERPRISES, INC. 2019 STOCK INCENTIVE PLAN, AS AMENDED AND RESTATED (2026) TO INCREASE THE NUMBER OF SHARES AUTHORIZED FOR AWARDS FROM 2,150,000 TO 2,950,000. Compensation |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| APPFOLIO, INC. | June 12, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 4 funds |
| ARDELYX, INC | June 16, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission (''Say-on-Pay''); Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| ARM HOLDINGS PLC | September 9, 2025 | Approve Remuneration Report Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| ARROWHEAD PHARMACEUTICALS, INC. | March 19, 2026 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| ARVINAS, INC. | June 24, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| ASTRONICS CORPORATION | May 28, 2026 | To approve the adoption of the Astronics Corporation 2026 Long Term Incentive Plan. Compensation |
Board | For | AGAINST 13 funds |
FOR 1 fund |
| AVEPOINT, INC. | May 5, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| AVIAT NETWORKS, INC. | November 5, 2025 | Advisory, non-binding vote to approve the Company's named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| AVIAT NETWORKS, INC. | November 5, 2025 | Approval of Third Amended and Restated 2018 Incentive Plan of the Company. Compensation |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| AVNET, INC. | November 21, 2025 | Advisory vote on named executive compensation. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 1 fund |
| AVNET, INC. | November 21, 2025 | Approval of the 2025 Stock Compensation and Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| AXOGEN, INC. | June 23, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| AXSOME THERAPEUTICS, INC. | June 5, 2026 | To approve, by non-binding advisory vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 4 funds |
| AYVENS | May 13, 2026 | APPROVE COMPENSATION OF PHILIPPE DE ROVIRA, CEO FROM DECEMBRE 1, 2025 Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| AYVENS | May 13, 2026 | APPROVE REMUNERATION POLICY OF PHILIPPE DE ROVIRA, CEO Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| Alignment Healthcare, Inc. | June 4, 2026 | Approval, on an non-binding, advisory basis, of the compensation of our Named Executive Officers Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 1 fund |
| Angi Inc. | June 10, 2026 | Election of Class II Directors: Glenn H. Schiffman Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| Arm Holdings Plc | September 9, 2025 | Elect Jeffrey A. Sine as Director Director Elections |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| Arm Holdings Plc | September 9, 2025 | Elect Masayoshi Son as Director Director Elections |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| Arm Holdings Plc | September 9, 2025 | Elect Rene Haas as Director Director Elections |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| Arm Holdings Plc | September 9, 2025 | Elect Ronald D. Fisher as Director Director Elections |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| BAKER HUGHES COMPANY | May 19, 2026 | The approval of the Baker Hughes Company 2026 Long-Term Incentive Plan Compensation |
Board | For | AGAINST 15 funds |
FOR 3 funds |
| BANC OF CALIFORNIA, INC. | May 6, 2026 | Approval, on an advisory and non-binding basis, of the compensation paid to the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 1 fund |
| BANK LEUMI LE-ISRAEL B.M. | September 15, 2025 | APPROVE GRANT OF OPTIONS TO FRIEDMAN HANAN SHMUEL, CEO Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| BASSETT FURNITURE INDUSTRIES, INC. | March 11, 2026 | PROPOSAL to consider and act on an advisory vote regarding the approval of compensation paid to certain executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| BEAM THERAPEUTICS INC. | June 3, 2026 | Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | Approval of an amendment to the 2004 Employee and Director Equity-Based Compensation Plan Compensation |
Board | For | AGAINST 12 funds |
FOR 2 funds |
| BEL FUSE INC. | May 26, 2026 | With respect to the approval of the 2026 Equity Compensation Plan Compensation |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| BERKSHIRE HATHAWAY INC. | May 2, 2026 | Non-binding resolution to approve the compensation of the Company's Named Executive Officers, as described in the 2026 Proxy Statement. Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 5 funds |
| BIM BIRLESIK MAGAZALAR A.S. | December 19, 2025 | Approve Share Capital Increase with Preemptive Rights Capital Structure |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Nominees: Arnold A. Pinkston Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Nominees: Melinda Litherland Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| BIO-TECHNE CORP | October 30, 2025 | Approve, on an advisory basis, the compensation of our executive officers. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 1 fund |
| BLACKLINE, INC. | May 7, 2026 | Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| BLACKROCK, INC. | May 20, 2026 | Approval, in a non-binding advisory vote, of the compensation for named executive officers. Say-on-Pay |
Board | For | FOR 17 funds |
AGAINST 10 funds |
| BLOOMIN' BRANDS, INC. | April 22, 2026 | Advisory Vote on Executive Compensation Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 1 fund |
| BLOOMIN' BRANDS, INC. | April 22, 2026 | Approval of the Amended and Restated Bloomin' Brands, Inc. 2025 Omnibus Incentive Compensation Plan Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| BLUE BIRD CORPORATION | March 11, 2026 | To approve the Blue Bird Corporation Amended and Restated 2015 Omnibus Equity Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 1 fund |
| BOARDWALK REAL ESTATE INVESTMENT TRUST | May 4, 2026 | ELECT TRUSTEE ANDREA GOERTZ Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| BOC AVIATION LTD | June 2, 2026 | Elect Chen Xiang as Director Director Elections |
Board | For | FOR 5 funds |
AGAINST 1 fund |
← Previous Page 2 of 8 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.